跳至主要内容
临床试验/NCT07254988
NCT07254988终止不适用

Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders

University of Copenhagen1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2023年3月24日最近更新:
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
3
试验地点
1
主要终点
CTX

研究概览

简要总结

Both GIP and GLP-2 reduce bone resorption (measured as CTX) in healthy adult individuals. In this study, we will investigate whether GIP and GLP-2 reduce CTX in children with spinal muscular atrophy, duchenne muscular dystrophy, or cerebral palsy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
10 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • - Diagnosis with Cerebral palsy (CP), Duchenne muscular dystrophy (DMD) or Spinal muscular atrophy (SMA) resulting in the need of a wheelchair

排除标准

  • Use of anti-resorptive medication
  • Confounding illnesses
  • Pregnancy
  • Allergy towards the components given on the test days
  • Hgb<6.5 mmol/L

研究组 & 干预措施

Meal test

Experimental

Oral liquid meal test

干预措施: Meal test (Other)

Glucose dependent insulinotropic polypeptide (GIP) + Glucagon-like-peptide 2 (GLP-2)

Experimental

Subcutaneous co-injection of GIP and GLP-2

干预措施: GIP + GLP-2 (Other)

Placebo

Placebo Comparator

Subcutaneous injection of saline

干预措施: Placebo (Other)

结局指标

主要结局

CTX

时间窗: -10 to 240 minutes

Bone resorption measured as carboxy-terminal telopeptide of type I collagen (CTX)

次要结局

  • P1NP(-10 to 240 minutes)
  • PTH(-10 to 240 minutes)
  • Glucose(-10 to 240 minutes)
  • GIP(-10 to 240 minutes)
  • GLP-2(-10 to 240 minutes)
  • Blood pressure(-10 to 240 minutes)
  • Heart rate(-10 to 240 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bolette Hartmann

Principal investigator

University of Copenhagen

研究点 (1)

Loading locations...

相似试验